The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,205.00
Bid: 9,185.00
Ask: 9,190.00
Change: 75.00 (0.82%)
Spread: 5.00 (0.054%)
Open: 9,015.00
High: 9,205.00
Low: 8,975.00
Prev. Close: 9,130.00
SPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Nov 2018 07:00

RNS Number : 4068H
Spirax-Sarco Engineering PLC
15 November 2018
 

 

 

News Release

 

Thursday 15th November 2018

TRADING UPDATE

Good performance in the four months to October, overall expectations unchanged

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, electrical thermal energy solutions and peristaltic pumping and associated fluid path technologies, issues the following trading update in respect of the period ended 31st October 2018.

 

Economic Environment

The global macro-economic environment for the Group remains positive with the latest forecast for Global Industrial Production (IP) growth for 2018 being 3.5%, marginally below the 3.6% forecast at the time of our Interim Report. As in the first half of the year, IP growth is weighted towards the emerging economies where the increase is forecast to be 4.9%, compared with 2.4% in the developed economies, much of the differential coming from China.

 

Trading

The Group's organic* sales growth rate in the four months to October increased modestly from that achieved in the first six months of the year, maintaining the good performance of the first half.

 

In EMEA, organic sales growth in the four months to October was slightly higher than in the first half of the year with the segment benefitting from a strong order book at the beginning of the period. Organic growth in Asia Pacific has continued to be strong with notably good performances from China and Australasia although growth in Korea was flat in the period against a strong comparison in the prior year. The good organic growth in the Americas has continued and was aided by a higher than anticipated devaluation of the Argentine peso in the period. Growth in the Watson-Marlow Fluid Technology Group continues to be strong, in line with that seen in the first half of the year.

 

The integration of Gestra and Chromalox, which joined the Group last year, continues progressing well. Their overall performance remains in line with our expectations and consistent with their performance in the first half of the year. The effect of these acquisitions is anticipated to increase the Group's full-year sales by approximately 11%.

 

Consistent with the first half-year performance, Group operating profit is ahead of the comparable ten-month period at constant currency, both on an organic basis and when the effects of the above acquisitions are included.

 

Currency effects are more muted this year than in the previous two years, and consistent with what we reported at the half-year remain a headwind. If spot rates at 31st October 2018 prevail for the remainder of the year, the negative impact of currency on sales and operating profit for the full year, compared with the full year 2017, would be slightly less than the 3% and 5% indicated at half-year. Movements in exchange rates are often volatile and unpredictable, therefore the actual impact could be significantly different.

 

Financial position

Our business remains highly cash generative and we maintain a strong balance sheet. At 31st October 2018 the net borrowings of the Group were £296 million. The interim dividend for 2018 of 29.0p per share was paid on 9th November at a cash cost of £21 million.

 

Outlook

Industrial production growth rates are forecast to remain positive for the remainder of the year in both developed and emerging markets although predictions for 2019 are less clear, with forecasters indicating a slightly lower level of IP growth in 2019 than in 2018. We continue with our investment programmes in support of future growth and the implementation of our strategy to generate growth from our own actions to outperform our markets. We achieve this by being more effective in identifying and generating engineered solutions to help our customers with energy efficiency, sustainability, productivity, quality, cost reduction and compliance with ever increasing regulatory requirements.

 

Whilst, as always, we have limited visibility due to the short-term nature of our order book, we have good diversification across market sectors and geographic regions and remain focused on our strategies for growth, which, together with the Group's fundamental strengths, stand us in good stead. We still have much to do in the remainder of this year but our overall expectations for the full-year are unchanged and the Board has confidence that the Group will make further progress in 2018.

 

Spirax Sarco expects to publish its preliminary 2018 results on 7th March 2019.

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Kevin Boyd, Chief Financial Officer

Tel: 01242 535234

 

Note: References to profit are to adjusted profit that excludes the amortisation and impairment of acquisition-related intangible assets and acquisition and disposal costs, together with the tax effects of these items.

* References to organic changes exclude acquisitions and disposals, and are expressed at constant currency.

 

About Spirax Sarco

Spirax-Sarco Engineering plc comprises two world-leading businesses, Spirax Sarco for steam and electrical thermal energy solutions and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. Spirax Sarco provides a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The business helps its end users to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 7,400 people, of whom over 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

 Further information can be found at www.spiraxsarcoengineering.com 

 RNS filter: Inside information prior to release

 

LEI 213800WFVZQMHOZP2W17

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFIESLFASEFF
Date   Source Headline
27th Nov 20134:20 pmRNSDirector/PDMR Shareholding
18th Nov 201312:36 pmRNSDirector/PDMR Shareholding
14th Nov 20134:28 pmRNSDirector/PDMR Shareholding
7th Nov 20137:00 amRNSInterim Management Statement
5th Nov 20134:24 pmRNSTotal Voting Rights
11th Oct 20139:08 amRNSDirector/PDMR Shareholding
2nd Oct 20132:00 pmRNSTotal Voting Rights
2nd Oct 20139:48 amRNSNotification of Release Date - IMS
23rd Sep 20138:41 amRNSHolding(s) in Company
3rd Sep 20138:56 amRNSTotal Voting Rights
30th Aug 20138:00 amRNSAcquisition
22nd Aug 20133:56 pmRNSHolding(s) in Company
13th Aug 20134:28 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNS2013 Half Year Results
7th Aug 201310:00 amRNSBoard Changes
6th Aug 20134:26 pmRNSTotal Voting Rights
12th Jul 20133:20 pmRNSDates for 2013 Half-Year Results
5th Jul 20135:24 pmRNSDirector/PDMR Shareholding
1st Jul 20133:17 pmRNSTotal Voting Rights
24th Jun 20133:34 pmRNSHolding(s) in Company
31st May 20137:00 amRNSAmendment to Official List
22nd May 20139:14 amRNSDirector/PDMR Shareholding
9th May 20134:22 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 20139:42 amRNSTotal Voting Rights
1st May 20138:53 amRNSChange of Director Details
18th Apr 20133:51 pmRNSHolding(s) in Company
12th Apr 20138:48 amRNSDirector/PDMR Shareholding
10th Apr 201311:01 amRNSDirector/PDMR Shareholding Replacement
10th Apr 20138:50 amRNSDirector/PDMR Shareholding
2nd Apr 201312:39 pmRNSTotal Voting Rights
22nd Mar 20139:41 amRNSAnnual Financial Report
19th Mar 20133:28 pmRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSDirector/PDMR Shareholding
7th Mar 20137:00 amRNSFinal Results 2012
6th Mar 20132:03 pmRNSTotal Voting Rights
26th Feb 20133:30 pmRNSDirector Declaration
5th Feb 20139:37 amRNSTotal Voting Rights
2nd Jan 20133:54 pmRNS2013 Key Dates
2nd Jan 20133:54 pmRNSTotal Voting Rights
2nd Jan 20133:54 pmRNSDirector/PDMR Shareholding
21st Dec 20125:21 pmRNSDirector/PDMR Shareholding
14th Dec 20129:07 amRNSDirector/PDMR Shareholding
6th Dec 20122:58 pmRNSDirector/PDMR Shareholding
3rd Dec 20124:03 pmRNSTotal Voting Rights
15th Nov 20128:25 amRNSHolding(s) in Company
8th Nov 20123:52 pmRNSHolding(s) in Company
7th Nov 20129:30 amRNSAcquisition
7th Nov 20127:00 amRNSInterim Management Statement
2nd Nov 20122:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.